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ABSTRACT  We  have shown  that  plasma membranes from  lymphoid  cells have inhibitory 
activity  for the growth  of normal lymphocytes and lymphoid  tumor cells (Stallcup, K. C., A. 
Dawson, and M.  F. Mescher, J. Cell Biol.  99:1221-1226).  This growth-inhibitory activity  has 
been found to co-purify with major histocompatibility  complex class I antigens (H-2K and D) 
when these cell surface glycoproteins are isolated from detergent lysates of cells by affinity 
chromatography  on monoclonal  antibody columns. When incorporated  into liposomes, the 
affinity-purified  H-2  antigens inhibited the growth  of both  normal lymphocytes  and tumor 
cells at concentrations  of  I-3 /~g/ml. Inhibition was  readily  reversed upon  removal of the 
liposomes from the cell cultures, even after several days of exposure of cells to the inhibitor. 
Inhibitory activity  was  insensitive to protease digestion or heat treatment,  indicating  that it 
was not due to the H-2 glycoproteins. This  was confirmed  by the demonstration that inhibitory 
activity  could be separated from the H-2 protein  by gel filtration  in the presence of deoxy- 
cholate and could be extracted from  membranes or H-2 antigen preparations with  organic 
solvents. The  results demonstrate  that  the  growth-inhibitory  component(s)  of the  plasma 
membrane is a minor lipid or lipid-like  molecule which retains activity in the absence of other 
membrane components. The findings reported here and in the preceding article suggest that 
this novel membrane component may have a role in control of lymphoid cell growth, possibly 
mediated by cell contacts. 
Many cultured adherent cell lines stop growing as the cultures 
reach monolayer confluence. The mechanisms responsible for 
this density-dependent growth control may include depletion 
of growth factors (1, 2), release of soluble inhibiting factors 
(3-5), or cell-to-cell contact (6-8). Evidence in support of a 
role for cell contact in growth control has been provided by 
observations that plasma membranes isolated from 3T3 cells 
inhibit DNA synthesis when added to in vitro cultures of 3T3 
cells (9,  10). This inhibitory activity can be recovered after 
detergent solubilization of the membranes and the inhibitor 
has been partially purified. The properties of the inhibitor 
indicate that it is a membrane protein(s) (11-13). 
Lymphoid cells also stop growing at high cell densities and 
resume growth upon dilution into fresh medium (14).  The 
basis of this growth regulation has not been extensively stud- 
ied.  Clearly,  any  of the  mechanisms  suggested  above  for 
density-dependent growth control of adherent cells may also 
be important in regulation of lymphoid cell growth. A role 
for cell contact in the growth regulation of lymphocytes is 
suggested by our finding that membranes isolated from these 
cells will inhibit in vitro growth of normal and transformed 
lymphocytes (15) and generation of immune responses (I 5a). 
Positive signals,  leading to lymphocyte proliferation and/ 
or differentiation, and normally resulting from cell-cell con- 
tacts,  can be provided by membranes from cells bearing the 
appropriate surface antigens (16,  17). The same membranes, 
at somewhat higher doses, inhibit growth and the inhibitory 
activity was found to co-purify with the plasma membrane 
(15).  Growth inhibition  resulted from a  decreased rate  of 
proliferation, not from any increase in the rate of cell death. 
The inhibition could be partially reversed by increasing the 
serum concentration in the medium, even after exposure of 
the cells to membranes for 24 h. Further evidence that the 
inhibitory activity was due to a membrane component(s) was 
provided by the  finding that it was  solubilized by treating 
membranes  with  detergent and  could  be  subsequently re- 
covered in reconstituted membranes formed upon removal of 
the detergent by dialysis. 
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and H-2D  in the mouse, are polymorphic  cell surface glyco- 
proteins  whose  recognition  by  lymphocytes  can  stimulate 
proliferation  and/or  differentiation  of the  lymphocytes  (18, 
19).  They  consist of a  glycosylated heavy chain  of ~47,000 
mol  wt,  which  spans  the  membrane,  and  a  noncovalently 
associated light chain  (#2-microglobulin)  of  13,000  mol  wt. 
These antigens have been purified from detergent solubilized 
membranes  by  affinity  chromatography  using  monoclonal 
antibodies bound  to  Sepharose (20,  21).  When  incorporated 
into  liposomes,  the  antigens  retain  activity  for  stimulating 
specific in  vitro  lymphocyte  responses (21-23).  This  report 
describes evidence demonstrating  that the growth-inhibitory 
activity of membranes  co-purifies with the H-2 antigens dur- 
ing  affinity  chromatography.  H-2  antigen-containing  lipo- 
somes were found to inhibit growth at concentrations of 1-3 
#g protein/ml. Because the liposomes can be readily separated 
from cells, it was possible to directly demonstrate  the revers- 
ible nature of the inhibition. Further study demonstrated that 
the inhibitor was not the H-2 glycoprotein but another mem- 
brane component  which co-purifies with it. Unlike the inhib- 
itory component  of 3T3  membranes  ( 11-13), the inhibitor(s) 
is  not  a  membrane  protein.  Instead,  it  is  a  minor  lipid  or 
lipidlike component  that can be extracted from H-2 antigen 
preparations or membranes  by organic solvents. 
MATERIALS  AND  METHODS 
Mice  and  Cell  Lines:  Mouse strains  I  used  in  these experiments 
included (BALB/c x  DBA/2)F~ (CD2FI)  from Cumberland Farms (Clinton, 
TN) and AKR, BALB/c, C57BL/6,  (C57BL/6  x  A/J)F~ (B6AF0,  and (AKR 
x  DBA/2)F~ (AKD2FI) from Jackson Laboratory (Bar Harbor, ME). Tumor 
cell lines used included P815,  a  mastocytoma, RDM-4,  a  lymphoma, the 
thymoma lines, EIA and BW5147, and RIE/TLSX. 1, a mutant lymphoma line 
(24). P815,  RDM-4, and EIA were routinely maintained by intraperitoncal 
passage in CD2F, AKR, and C57BL/6 mice, respectively. BW5147 and RIE/ 
TL8X.1  were maintained in vitro.  Tumor cells were grown in vitro at 37"C 
using RPMI  1640 (Gibco Laboratories,  Grand Island Biological Co., Grand 
Island, NY) supplemented with 10% fetal calf serum, 2 mM giutamine, 50 U/ 
ml penicillin, and 50 pg/ml streptomycin. 
Assay  of  Cytolytic  T  Lymphocyte  (CTL)  2  Responses: 
CD2F, mice were immunized by intraperitoneal injection of 2 x  10  ~ RDM-4 
tumor cells. 4-6 wk later, spleen cells were removed and placed in culture (7 x 
10  ~ cells per 2  ml of culture volume) and H-2 antigen was added.  Control 
cultures were done in parallel without added antigen.  5 d later the cells were 
harvested,  washed, and counted, and mixed with S~Cr-labeled RDM-4 target 
cells. After 4 h at 37"C, cells were pelleted, supernatants collected, and the StCr- 
release determined. Percent specific release was calculated  as (E -  C)/(FT - 
C) x  100, where E is isotope release from tubes containing immune effector 
cells plus targets, C is isotope release from tubes containing normal spleen cells 
plus targets, and FT is maximum isotope release determined after four cycles 
of freezing and thawing the target cells. Details of the culture conditions and 
chromium release assay have been published (16). 
Assay of Growth-inhibitory Activity 
TUMOR CELL GROWTH:  In vitro growth of tumor cells was done in 2- 
Animals used in this study were maintained in accordance with the 
guidelines of the Committee on Animals of the  Harvard  Medical 
School and those prepared by the Committee on Care and Use of 
Laboratory Animals of  the Institute of  Laboratory Animal Resources, 
National Research Council (Department of Health, Education, and 
Welfare publication no. [National Institutes of  Health] 78-23, revised 
1978). 
2Abbreviations  used  in  this paper.  CTL,  cytolytic  T  lymphocyte; 
DOC, deoxycholate; LPS, lipopolysaccharide; MAb, monoclonal an- 
tibody; TBS,  Tris-buffered saline; Tdr,  thymidine; TX-100,  Triton 
X-100. 
cm  2 Linbro wells (Linbro Chemical Co., Hamden, CT) in 2 ml of RPMI 1640 
supplemented with  10%  fetal  calf serum, 2  mM glutamine, and  50  U/ml 
penicillin and 50 #g/ml streptomycin. Cultures were incubated at 37"C in a 5% 
CO2 atmosphere. Growth was assessed by cell counting using a hemocytometer, 
and trypan blue was included to allow an estimate of the number of dead cells 
present.  Standard deviation of triplicate or quadruplicate samples was +_10% 
or less. 
[3H]THYMIOXNE (Tdr)  iNCORPORATION ~¥  TUMOR CELLS:  [3H]- 
Tdr incorporation by BW5147 tumor cells was measured as described in the 
preceding  article (15). Tdr incorporation in the presence  of  inhibitor is expressed 
as percent control, where control is the amount of radioactivity  incorporated 
in identical cultures that were not exposed to inhibitor. All samples were done 
in quadruplicate and standard deviations ranged from +_2% to _+ 10% (expressed 
as percent of control). 
LIPOPOLYSACCHARIDE  (LPS)-INDUCED MITOGENIC  RESPONSE: 
The mitogenic response of normal spleen B cells to LPS was measured by 
[SH]Tdr incorporation as described in the preceding article (15). Unless indi- 
cated otherwise, spleen cells from BALB/c mice were used in the assays. Tdr 
incorporation in the presence of inhibitor is expressed as percent of control, 
where control is the incorporation in identical cultures that were not exposed 
to inhibitor. Standard deviations of quadruplicate samples averaged +- 10% or 
less, expressed as percent of control. The stimulation index, a measure of the 
efficacy of mitogen-induced proliferation (described  in the preceding article 
[15]) is included in the figure legend for each experiment. 
Membrane  Isolation:  n  membrane preparation,  containing both 
plasma membrane and endoplasmic reticulum, was isolated from tumor cells 
as described previously (l 6) and in the preceding article (15). In some cases the 
membranes were further fractionated by sucrose density-gradient centrifugation 
to yield fractions enriched in either plasma membrane or endoplasmic reficu- 
lum (15, 16). 
Affinity Purification of H-2K and D Antigens:  H-2 antigens 
were affinity purified using monoclonal antibodies (MAbs) covalently coupled 
to Sepharose 4B (Pharmacia Fine Chemicals, Piscataway, NJ). The 11-4.1 MAb 
(25) was used for purification of  H-2K  k from RDM-4 cells. M 1/42, an antibody 
specific for H-2 glycoproteins  but lacking haplotype specificity (21), was used 
for purification  of H-2K  d and I~ from P815 cells. The purification procedures 
using these MAbs have been described  in detail  (20,  21, 26). Briefly, tumor 
cells or membranes bearing the appropriate antigen(s) were lysed by suspension 
in 0.5%  Triton X-100 (TX-100)  at 4°C. The lysate was then centrifuged  to 
remove insoluble  material,  passed over a Sepharose  4B precolumn and then 
over the MAb-Sepharose column. After loading, the MAb column was washed 
with 5-10 column volumes of the lysis buffer and the bound antigen then 
eluted with 0.5% deoxycholate (DO(2) in 0.14  M NaCI,  10 mM "Iris, pH 8 
(Tris-buffered saline, TBS)for 11-4.1 columns, or 0.5% DOG, 0.5 M NaCI in 
TBS for M 1/42 columns. Because TX-100 is toxic to cells, the first two or three 
elution fractions  containing antigen were usually  not included in the final 
pooled antigen preparations. Although resulting  in a decreased  yield of H-2 
antigen, this avoided the possibility of  TX-100 carry-over and potential effects 
of the detergent in cell growth experiments. (TX-100 is readily detectable by 
thin-layer chromatography and was not found in the H-2 antigen preparations 
examined in this manner.) 
In most purifications,  a small number of cells (5-10 x  107) were surface 
labeled with ~2sI by lactoperoxidase-catalyzed  iodination, lysed with TX-100, 
and added to the bulk  cell  lysate  to  allow  monitoring of the purification 
procedure (26). Preparations were normally done using l0  ~° or more cells and 
yields were -0.8 mg H-2K  k per 10 ~° RDM-4 cells and 0.1-0.2 mg H-2KdD  d 
from PSI5 cells. In some cases, both H-2K  k and H-21~' were purified from 
RDM-4 by serial passage of the lysate over an 11-4.1 column (H-2K  k) followed 
by an M1/42 column (H-21~') (21). 
Incorporation  of H-2 Antigens  into  Liposomes:  Lipids used 
for formation of liposomes were obtained by chloroform/methanol (2:1) ex- 
traction of P815 cells (22). The extract was washed with 0.3 vol of water, dried 
under an N2 stream, suspended in 0.5%  DOG in TBS, and stored at -20°C 
until used. Lipid concentrations  were determined as organic phosphate content. 
Yield of extracted lipid was ~ 10 #mot phospholipid per 109 cells. A detergent- 
insoluble matrix from membranes was included in some liposome preparations 
(22). It was prepared by extracting membranes (at  1 mg/ml) with 0.5% TX- 
100 in TBS for 20  rain at 4°C, centrifuging  at  100,000 g for 45  rain, and 
washing the pellet once in PBS. The washed pellet was then resuspended in 
0.5% DOC in TBS. This insoluble material accounts for -20% of  the membrane 
protein and consists of  a protein matrix present in the form of  structures having 
the same size distribution as the original membrane vesicles (27). 
Preparation of H-2 antigen-containing liposomes by detergent dialysis and 
their characterization  have been previously  described (22). Briefly, liposomes 
were prepared by mixing affinity-purified  H-2 antigen (in 0.5%  IX)C, TBS) 
with lipid at a ratio of I zg protein to 5-10 nmol phospholipid (~ 1 mol protein/ 
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using dimyristoyl phospbatidyl  choline (Sigma Chemical Co., St. Louis, MO) 
at a ratio of I tag H-2 antigen to 1 tag dimyristoyl phosphatidyl choline, instead 
of lipids extracted from P815 cells. Mixtures were then dialyzed versus 4 liters 
of TBS for 24 h and then versus 4 liters TBS, 4 mM CaC12 for an additional 
24 h. The resulting liposomes were concentrated  by centrifuging the dialyzed 
mixture for 90 min at 100,000 g. Under these conditions,  ~50-70% of  the lipid 
and H-2 antigens are recovered in the pellet in the form of small unilamellar 
vesicles and most of the protein is exposed to protease at the liposome surface 
(22). 
In eases where the membrane matrix was included, the starting mixture in 
0.5% DOC contained  H-2, matrix, and lipid in the proportions of I tag H-2, 10 
tag matrix, and 13 nmol lipid. Dialysis and concentration  was done as described 
above. It appears that a bilayer, with incorporated  H-2, reforms on the mem- 
brane matrix  under these conditions  (22). The resulting liposomes are larger 
and more irregular in shape than those obtained using  just lipid and protein. 
Heat and  Protease Treatment of H-2Kk:  In  experiments  to 
examine  stability  of the  growth  inhibitory  activity,  affinity-purified  H-2K  k 
(containing a trace of t251-H-2) in 0.5% DOC, TBS was heat or protease treated 
before formation of liposomes. Heat treatment was done by incubating  a  15 
ug/ml solution at 100*C (boiling water bath) for 10 min, followed by cooling 
on ice. Protease treatment was done by incubating  22 ttg/ml  H-2K  k with 56 
tag/ml pronase (Caibiochem-Behring  Corp.,  San  Diego, CA) in 0.5% DOC, 
TBS with  10 mM CaCI2 for 24 h at 37"C. Fresh pronase (56 tag/ml) was then 
added  and incubation  continued  for 19 h at 37*(7. Liposomes were prepared 
from untreated  and treated  H-2K  k using 7.5  nmol lipid per 1 tag of starting 
protein (before treatment).  80% of the nSI-H-2 radioactivity was recovered after 
dialysis of the untreated  and heat-treated  samples. Less than 5% of the radio- 
activity was recovered with the pronase-treated sample. 
Gel  Filtration  of  H-2  Antigens  and  Solubilized Mem- 
branes:  Gel filtration was done on a 120 x 0.75-cm Bin-Gel A, 0.5 M (Bio- 
Rad  Laboratories,  Richmond,  CA) column equilibrated  with 0.25% DOC in 
TBS. Column calibration  was done using Blue Dextran  (excluded volume), 
bovine serum albumin (68,000 mol wt), ovalbumin (45,000 mol wt), ribonu- 
clease A (13,700 tool wt), and fluoreseein malaemide  (included volume). The 
column was eluted  at a flow rate of ~20 ml/h and fractions of 2.8 ml were 
collected. Affinity-purified t251-H-2 in 0.5% DOC, TBS was applied directly to 
the column. Membranes were solubilized in 0.5% DOC, TBS at a detergent to 
protein  ratio  of 5:1  for 20  min at 4°C. The sample  was then centrifuged at 
100,000 g for 45 rain to pellet insoluble  material (-20% of the total protein) 
and the soluble fraction applied to the column. 
Inhibitory  activity in the fractions was determined  by removing an aliquot 
of each fraction, adding lipid, and dialyzing to form liposomes. Each liposome 
sample was then tested at four concentrations  over an eightfold concentration 
range for inhibition  of an LPS-induced  mitogenic  response. The amount of 
material needed for 50% inhibition of  the response was defined as one inhibitory 
unit and the total units in each fraction was calculated as T/[(S/LXX)], where 
T is the total volume of the fraction, S is the volume of aliquot used to make 
liposomes, L is the volume of medium used to resuspend the liposome pellet, 
and X is the volume of liposome suspension needed for 50% inhibition  of the 
response. 
Organic  Extraction  and  Thin-layer  Chromatography: 
Organic extractions  were done using 2:1  l-butanol/6 M pyridinium  acetate, 
pH  4.2. Affinity-purified  H-2  antigens  (at  15-30  #g/ml) and  gel  filtration 
fractions containing inhibitor were dialyzed overnight versus 4 liters of 50 mM 
NaCI before extraction (to remove DOC). To control for possible introduction 
of inhibitory  material  from the organic solvents, we extracted equal volumes 
of buffer and processed them in the same way as the samples. Extraction was 
done by mixing equal volumes of sample and butanol/6 M pyridinium acetate 
and incubating for 30 min at room temperature with occasional vortexing. The 
mixtures were then centrifuged and the organic and aqueous phases collected 
and dried  under an N2  stream  at 40-45"C.  0.5% DOC,  TBS was added  to 
dissolve the dried films, lipid added (5 nmol/t~g starting H-2 Ag) and liposomes 
prepared.  Membranes were suspended  in 50  mM NaC1 at 0.75 mg/ml and 
extracted and dried in the same way. Serum-free RPMI 1640 medium was then 
added, and the dried films were resuspended using a bath sonicator. 
Thin-layer chromatography was done on silica gel G plates (Analtech, Inc., 
Newark, DE) using a solvent system of chloroform/methanol/H20, (60:35:8). 
Samples were applied directly to the plates in aqueous buffer and dried. Lipid 
standards (Supelco Inc., Bellefonte, PA) were applied in chloroform/methanol 
( l: 1). After developing and drying the plates, lipids were visualized by exposure 
of the plate to iodine vapor. 
Analytical  Methods:  Protein  concentration  was determined  by the 
method of Lowry et  al.  (28) in the presence of 1%  SDS using BSA as the 
standard. Organic phosphate was determined  as described by Ames and Dubin 
(29). SDS PAGE was done using the buffer system described by Laemmli (30) 
with a 3% stacking gel and a running gel consisting of a 5-15%  gradient  of 
polyacrylamide.  Before  electrophoresis,  samples  were  reduced  with  5%  ~- 
mereaptoethanol  and heated for 3 min at 100°C in sample application buffer. 
After electrophoresis proteins were visualized by staining with Coomassie Blue 
and autoradiography  was done to visualize J25I-labeled protein  using Kodak 
XR5 film (Eastman Kodak, Inc., Rochester, NY). 
RESULTS 
Co-purification  of H-2 Antigens and Growth- 
inhibitory Activity 
Purification of H-2 antigens by affinity chromatography on 
MAb-Sepharose columns results in good yields (70-90%) of 
highly purified antigen (20, 21, 26). When examined by SDS 
PAGE, the  only major bands detected by Coomassie Blue 
staining are the glycosylated heavy chain of ~47,000 mol wt 
and the noncovalently associated B2-microglobulin  of 13,000 
mol wt (not shown). Minor contaminants can sometimes be 
detected but are not reproducibly seen, and in many prepa- 
rations are undetectable. 
The purified H-2K and D glycoproteins can be incorporated 
into small unilamellar liposomes by dialysis to remove deter- 
gent from a mixture of the protein and lipid in DOC (22). In 
this form, the antigens are active in stimulating generation of 
an allogeneic CTL response (21, 22), a response that depends 
upon lymphocyte recognition of H-2 antigens via cell surface 
receptors. Recognition of the antigen was found to be more 
effective if a detergent-insoluble matrix fraction isolated from 
plasma  membrane  vesicles  was  included  during  liposome 
formation (22).  Stimulation  of a  CD2F1  (H-2  d)  anti-H-2  k 
CTL response by H-2K  k containing liposomes is shown in 
Fig.  1A.  Consistent with  previous results,  a  response was 
generated when antigen was added to the cultures at 0.05-0.5 
#g/ml. However, the level of response decreased dramatically 
when antigen concentration was increased to 1-2 ug/ml (Fig. 
IA). 
A  variety of mechanisms,  including specific immune re- 
sponses, might account for a  decreased CTL response to a 
high dose of antigen. However, as described in the preceding 
article (15), we had found that plasma membranes of lymph- 
oid  cells contain  an  inhibitor  of normal  lymphocyte and 
lymphoid tumor cell growth. This raised the possibility that 
the growth-inhibitory activity was co-purifying with the H-2 
antigens  and  that  it was  this  inhibitor that  was  acting  to 
decrease the CTL response at the higher antigen concentra- 
tions. We therefore examined the effect of H-2 antigen-con- 
taining liposomes on the in vitro growth of lymphoid tumor 
cell lines and the mitogenic response of spleen cells to LPS, 
both of which are inhibited by membranes (15). 
Liposomes containing the membrane matrix and either H- 
2K  k (purified using the  11-4.1 MAb) or H-2K  d and D d anti- 
gens (purified using the  M1/42  MAb)  were added to  low 
density cultures of P815  cells  and the number of live cells 
determined 3 d later. Both types of liposomes caused a dose- 
dependent  inhibition  of cell  growth  (Fig.  1  B),  with  50% 
inhibition  occurring between 0.5  and  1 #g/ml.  Liposomes 
prepared with identical lipid and membrane matrix but in the 
absence of purified H-2 antigens were also examined. These 
liposomes had no effect on the cell growth (Fig.  1  B).  H-2 
antigen-containing liposomes (using a number of  independent 
antigen  preparations)  were  also  found  to  inhibit  in  vitro 
growth of EL-4, CH-1, and RDM-4  lymphoid tumor cells, 
and 14-4.4 and 10-2.16 hybridoma cells (not shown). In every 
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FIGURE  1  Inhibitory activity of purified  H-2  antigens (H-2  Ag)  in 
liposomes. (A) Stimulation and inhibition of a CTL response. H-2K  k 
was incorporated into liposomes using lipid and membrane matrix. 
Liposomes were added to cultures of CD2F, spleen cells from mice 
previously immunized with RDM-4 (H-2 k) cells. Cells were removed 
from culture 5 d  later, washed, and assayed for lytic activity using 
5~Cr-labeled RDM-4 target cells. Data shown were obtained at an 
effector/target ratio of 60:1. Spleen cells maximally stimulated with 
6 x  106 x-irradiated AKR (H-2 k) cells gave 80% specific release. (B) 
Inhibition  of  P815  tumor cell growth.  Liposomes were prepared 
from lipid, membrane matrix, and either H-2K  k (@) or H-2KdD  d (A), 
or without H-2 antigen (O). P815 cells were put into culture at 1.25 
x  104 cells/ml in 2  ml of medium with or without liposomes and 
counted  3  d  later. Control cultures had 8.8 x  105 +  5% cells/ml 
(100% control). (C)  inhibition of mitogen-induced proliferation of 
BALB/c B cells. Spleen cells from BALB/c mice were stimulated in 
vitro  with  LPS  in  the  presence  or  absence  of  H-2  antigen  as 
described in Materials and Methods.  [3H]Tdr incorporation in the 
absence of inhibitor was 39,000 _  2,000 cpm and the stimulation 
index was 9.8. Liposomes were prepared using only lipid (O), lipid 
and  H-2K k (0),  or  H-2D k (V). Affinity-purified  H-2K  k was also di- 
alyzed to remove DOC  in the absence of added lipid. The final 
dialysis was done versus  PBS and the dialyzed sample was added 
directly to the cultures (x). (D) Inhibition of mitogen-induced pro- 
liferation of  B10.Br  B  cells.  Spleen  cells  from  B10.Br  mice were 
stimulated in  vitro with  LPS  in  the  presence or  absence of  H-2 
antigen as described in Materials and Methods. [3H]Tdr incorpora- 
tion in the absence of inhibitor was 24,000 -  3,000 cpm and the 
stimulation index was 10.7. Liposomes were prepared using dimy- 
ristoyl phosphatidyl choline and H-2K  k (0) or H-2  d (A)- 
case, the dose response was similar to that shown in Fig.  1  B, 
with 50% inhibition occurring at 0.5-1.5 ~g/ml H-2 antigen. 
In all  of these  experiments,  the  proportion  of trypan  blue 
including (dead) cells was the same in control and inhibited 
cultures. 
Liposomes containing either  H-2K  k,  H-2D  k or H-2KdD  d 
were also examined for their effect on the mitogenic response 
of B lymphocytes from two different strains of mice, BALB/ 
c  and  B10.BR.  In  every case,  the  H-2  antigen-containing 
liposomes were inhibitory, while liposomes lacking the anti- 
gen  were not  (Fig.  1,  C  and  D).  Similar results have been 
obtained in experiments examining the response of cells from 
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CD2F~  and C57BL/6  mice (not shown).  Thus,  the growth- 
inhibitory activity does not appear to be genetically restricted, 
as it is neither haplotype nor strain specific.  Small differences 
in the dose-response curves for different H-2 antigen prepa- 
rations were sometimes seen in individual experiments (Fig. 
1  D) but these differences were not consistently reproducible. 
In experiments examining many independent  H-2  antigen 
preparations,  50%  inhibition  of the  LPS-induced  response 
occurred in the range of 0.5-6 ug/ml. 
While including the detergent-insoluble membrane matrix 
in liposomes increases the efficiency of H-2 antigen recogni- 
tion by CTL (22), this was not the case for growth-inhibitory 
activity. The liposomes used in the experiments shown in Fig. 
1,  C  and  D  were  made  using  only lipid  and  purified  H-2 
antigens,  and the  control  liposomes from lipid  alone.  Fur- 
thermore, addition of lipid to the H-2 antigen preparation to 
form liposomes was not required.  Removal of detergent by 
dialyzing of the H-2 antigen solution in the absence of lipid 
resulted  in  good  recovery of the  growth-inhibitory activity 
(Fig.  1C). 
Growth Inhibition Is Reversible 
Experiments done using membranes provided strong evi- 
dence  that growth  inhibition  occurred as a  result  of a  de- 
creased rate of cell growth and was not due to an increased 
rate of cell death (15).  Increasing the concentration of fetal 
calf serum in membrane-inhibited cultures resulted in some 
reversal of inhibition (15). However, attempts to more directly 
demonstrate  reversal by  removing the  inhibitor were  only 
partially successful (unpublished results), probably due to the 
difficulty  of separating  the  membranes  from  the  cells.  A 
relatively homogeneous population  of small (0.03-0.1  ~m) 
unilamellar liposomes results from dialysis to remove deter- 
gent (22) and these liposomes can be readily separated from 
cells by differential centrifugation (31).  It was therefore pos- 
sible to directly examine the reversibility of inhibition  me- 
diated by H-2 antigen-containing liposomes. 
P815 tumor cells were placed in culture at low density with 
and without H-2Kk-containing liposomes. After 3 d, cultures 
in the presence of liposomes contained 80% fewer cells than 
controls (Fig.  2A). At this time cells from inhibited cultures 
were  washed  by  differential  centrifugation  to  remove  the 
liposomes, placed back into culture, and examined 2 d later. 
Removal of the  liposomes resulted  in  an increased growth 
rate, and by day  5 the washed cells had  reached the  same 
density as control cultures. In contrast, calls left in the pres- 
ence of liposomes continued to grow very slowly and, by day 
5, had -70% fewer cells than in control or washed cultures. 
Thus, cells exposed to inhibitor for 3 d, with 80% inhibition 
occurring, remained viable and resumed normal growth upon 
removal of the inhibitor. 
The dose response for inhibition occurs over a very narrow 
concentration  range,  with  a  twofold  increase  in  inhibitor 
concentration  resulting in  a  60-90%  increase in  inhibition 
(Fig.  1).  Because  of this  sharp  dose  response,  it  was  also 
possible to demonstrate reversal by simply lowering the lipo- 
some  concentration  in  inhibited  cultures  by dilution  with 
medium. In the experiment shown in Fig. 2 B, RDM-4 tumor 
cell growth was almost completely inhibited by 1.2 gg of H-2 
antigen/ml  in  liposomes,  but  the  cells  resumed  a  normal 
growth rate upon lowering the concentration of liposomes to 
0.6 ~g protein/ml by dilution. Thus, as with P815 cells, RDM- 
4 cells remained viable in the presence of inhibitor for days ¢~ 105 
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FIGURE  2  Growth inhibition by H-2 antigen-containing liposomes 
is  reversible.  (A)  Reversal of  inhibition  by  removal of liposomes. 
P815 cells were put into culture at a density of 1.6 x  104 cells/ml 
in the presence or absence of liposomes. Liposomes were prepared 
using dimyristoyl phosphatidyl choline, membrane matrix, and H- 
2K  k and were used at 5/~g of H-2/ml. Cells were counted on days 
3 and 5. At day 3, parallel cultures were either left under the same 
conditions or the cells were removed, washed once by centrifuga- 
tion (I ,600 rpm in a CRU centrifuge for 10 rain) to remove liposomes 
and placed back into culture.  Controls without liposomes, either 
unwashed (--O--) or washed (--O---). H-2K  k liposomes added and 
cells unwashed (--0--) or washed (--O---). (B) Reversal of inhibition 
by dilution of liposomes. RDM-4 cells were put into culture at I  x 
I0  s cells/ml in the  presence or absence of liposomes. Liposomes 
were prepared using lipid and H-2K  k and were added at an initial 
concentration of 0.8 or 1.2 #g of H-2/ml. On day 2, I  ml of the 2- 
ml cultures was removed and the cells were counted. I  ml of fresh 
medium was then added to the  remaining cultures and the cells 
were counted again on day 4. Controls in the absence of liposomes 
(O);  liposomes present initially at 0.8 #g of H-2/ml  and diluted to 
0.4/~g/ml on day 3 (A); liposomes present initially at 1.2/~g/ml and 
diluted to 0.6 ~tg/ml on day 3 (@). 
but resumed active growth when the liposome concentration 
was diluted below the threshold level needed for inhibition. 
These results further confirm that inhibition is not due to a 
toxic effect resulting in cell death but instead acts by slowing 
the growth rate of the cells. 
Growth Inhibitor(s) Is Not the H-2 Glycoprotein 
Although H-2 antigens isolated by affÉnity chromatography 
on MAb-Sepharose columns are highly purified, the possibil- 
ity existed that the growth-inhibitory activity was not due to 
the H-2 glycoprotein but to another membrane component 
which  co-purified with  the  H-2 antigens.  We therefore ex- 
amined  the  effects of heat  and  protease treatment  on  the 
inhibitory activity. The activity was found to be heat stable, 
even after incubation  of the  H-2  antigen  preparation  in  a 
boiling water bath for l0 min (Fig.  3). Furthermore, most of 
the inhibitory activity was recovered after papain (not shown) 
or pronase treatment (Fig. 3). To monitor the effectiveness of 
the pronase treatment, we used  tzSI-H-2Kk in these experi- 
ments.  Pronase  treatment  of the  sample  before  liposome 
formation resulted in loss of all of the radioactivity from the 
dialysis bag during DOC removal and liposome formation. 
Thus, the resulting liposomes retained inhibitory activity (Fig. 
3) despite extensive degradation of the H-2 glycoprotein. The 
small (and variable) loss of inhibitory activity after protease 
treatment may result from a decreased recovery of liposomes 
in the absence of protein. 
Further  evidence that  the  H-2  glycoprotein was not  the 
inhibitor was provided by examination of the inhibitory ac- 
tivity of membranes from a  mutant cell line, R1E/TL8X-1 
(24), which does not express H-2 antigens on the cell surface. 
Membranes from these cells had growth-inhibitory activity 
comparable to that found for membranes from RDM-4 (not 
shown) and other cells bearing H-2 antigens. 
These results strongly suggested that the inhibitor was nei- 
ther the H-2 glycoprotein nor dependent on the protein for 
activity. This was directly confirmed by the finding that H-2 
antigens and the inhibitor could be separated by gel filtration 
in DOC (Fig. 4A). Affinity-purified ~zSI-H-2Kk  was applied to 
a  Bio-Gel A  0.5  M  column and elution done using 0.25% 
DOC  in  TBS.  The  H-2  glycoprotein  eluted  at  a  position 
corresponding to an apparent mol wt of ~ 1 I0,000. While the 
mol wt of H-2 antigens is -60,000,  these proteins elute at 
higher apparent molecular weights on gel filtration in deter- 
gent (32), probably as a result of  interaction with the detergent. 
In order to locate the inhibitor, equal volume aliquots of each 
fraction were then mixed with lipid, dialyzed to form lipo- 
somes, and tested for inhibitory activity in a B cell prolifera- 
tive response. The growth-inhibitory activity was recovered as 
a single peak at an apparent mol wt of 35,000, well separated 
from the H-2 glycoprotein. 
The inhibitory activity present in  P815  membranes was 
also examined by gel filtration in DOC (Fig. 4B). Membranes 
were  solubilized in  0.5%  DOC  in  TBS and  centrifuged  at 
100,000  g  for 45  min  to  remove insoluble  material.  This 
insoluble fraction contains <5 % of the inhibitory activity (15) 
and was discarded. The soluble fraction was applied to the gel 
filtration column and elution done using 0.25% DOC in TBS. 
Fractions  were  assayed  for  protein  content  (A28o) and  for 
growth-inhibitory activity. A small peak of activity was found 
in the void volume of the column but most of the activity 
was recovered in a peak eluting at the same position as that 
found for inhibitor present in H-2 antigen preparations. DOC 
solubilized RDM-4  membranes were also examined by gel 
filtration and the inhibitory activity was recovered in the same 
region. A trace amount of z25I-H-2Kk was added to the solu- 
bilized membrane samples before gel  filtration.  It eluted in 
the  same position  (not  shown)  as  H-2  antigen  run  in  the 
absence of other membrane proteins (Fig. 4A). 
These results clearly demonstrated that the growth inhibitor 
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FIGURE 4  Separation of growth inhibitor from H-2 antigen by gel 
filtration. Gel filtration was done on a Bio-Gel A 0.5 M column in 
0.5% DOC, TBS. Details of sample preparation, gel filtration, and 
assay of inhibitory activity are described in Materials and Methods. 
Elution positions of standard proteins are indicated at the top of A. 
(A) Gel filtration of affinity-purified H-2K  k. 125 #g of H-2K  k, includ- 
ing a trace of uSI-H-2K  k, was applied to the column and fractions 
were assayed for uSI-H-2 (O) and growth-inhibitory activity (O). (B) 
Gel filtration of DOC-solubilized membranes from P815 cells. The 
DOC-soluble fraction from  10 mg of membranes  was applied to 
the column and fractions assayed for A~a0 (  ) and growth-inhib- 
itory  activity  (-O--). Also  shown  is  the  elution  profile  of  [3H]- 
phosphatidyl choline (----) determined in  a separate experiment 
using the same column and conditions. 
present in H-2 preparations was not the H-2 glycoprotein nor 
dependent on it for activity. They also provided additional 
evidence  that  the  inhibitor  that  co-purifies  with  the  H-2 
antigens is the same as the one that accounts for the growth- 
inhibitory activity of membranes. Co-purification of the in- 
hibitor and H-2 antigen upon affinity chromatography using 
MAbs specific for determinants on the H-2 glycoprotein may 
indicate an association between the antigen and the inhibitor. 
If such association occurs, it appears that it is retained in the 
presence of TX-100, used for cell solubilization and binding 
to the column, but not in the presence of DOC. The basis for 
co-purification  of H-2  antigen  and  the  inhibitor  is  being 
investigated. 
Lipid-like Nature of the Growth Inhibitor 
The heat and protease insensitivity of the inhibitor (Fig. 3) 
suggested that it might be a lipid or lipid-like component of 
the membrane. This suggestion is not inconsistent with the 
elution of inhibitory activity at an apparent mol wt of 35,000 
on gel filtration in DOC. [3H]phosphatidyl choline was found 
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to elute at the same position (Fig. 4B), indicating that this is 
the  elution  position  of mixed  micelles of DOG  and  lipid. 
Behavior of the inhibitor upon extraction with organic sol- 
vents was therefore examined. 
Affinity purified H-2K  k was dialyzed to remove DOC and 
extracted with 2: l  butanol/pyridinium acetate, pH 4.2.  The 
aqueous and organic phases were dried under an N2 stream, 
the residues were dissolved in 0.5%  DOC in TBS, lipid was 
added, and liposomes were formed by dialysis.  The resulting 
liposomes were tested for the ability to inhibit B cell prolifer- 
ation in comparison with an equal amount of unextracted H- 
2K  k in liposomes. The growth-inhibitory activity was quan- 
titatively recovered in the organic phase (Fig. 5 A). Membranes 
from RDM-4 cells were extracted in the same way, and the 
inhibitory activity was again quantitatively recovered in the 
organic phase (Fig.  5 B).  Similar results were obtained when 
membranes from  P815  cells were  extracted with  butanol/ 
pyridinium acetate and when  inhibitor-containing  fractions 
from gel  filtration  of membranes or  H-2  antigen  were ex- 
tracted (not shown). 
Extraction of H-2 antigen preparations and membranes has 
also  been  done  using  chloroform/methanol/H20  (2:1:0.3). 
Again, the  inhibitory activity was recovered in  the organic 
phase in both cases. Using H-2 antigen preparations, it was 
shown that the inhibitor did not have to be incorporated into 
liposomes by addition  of exogenous lipid to be active (Fig. 
1 C). Consistent with this observation, we have found that the 
inhibitory activity can be recovered from the dried organic 
extract either by adding DOC  and lipid and  forming lipo- 
somes, or by adding culture medium or buffer and sonicating 
in a bath sonicator to disperse the residue. 
It is important to note that the P815 whole cell lipid extract 
used to make the liposomes for the  experiments shown in 
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FIGURE 5  Inhibitory activity is soluble in organic solvents. Affinity- 
purified  H-2K  k,  an equal volume of buffer  (buffer  control),  and 
membranes were extracted with butanol/6 M  pyridinium acetate, 
pH 4.2. The separated aqueous and organic phases were dried and 
dissolved in 0.5% DOC, TBS. Lipid was added and liposomes were 
prepared as described in Materials and Methods. Liposomes were 
then  tested  for  inhibitory activity  in  an  LPS-induced  mitogenic 
response. Concentrations of H-2  antigen and  membrane are ex- 
pressed as  protein content of the sample  before extraction. (A) 
Extraction of purified H-2K  k.  Incorporation of [3H]Tdr  in the ab- 
sence of liposomes  (100% control) was 87,000  _  3,000 cpm and 
the stimulation index was 34. Unextracted H-2K  k (O); H-2K k, organic 
phase (A); H-2K k, aqueous phase (A); buffer control, organic phase 
(~7); buffer control, aqueous phase (V). (B) Extraction of membranes 
from RDM-4 cells. Incorporation of [3H]thymidine in the absence 
of liposomes (100% of control) was 153,000 4- 10,000 cpm and the 
stimulation  index was  7.9.  Unextracted  membranes  (O); mem- 
branes, organic phase (O). FIGURE 6  Lipid  composition  of 
RDM-4 membranes  and affinity pu- 
rified  H-2K  k.  Amounts  of  RDM-4 
membrane (78 ~g/ml; lane A) and H- 
2K  k (7  #g;  lane  B)  that  had  equal 
growth-inhibitory activity  were  ex- 
amined  by  thin-layer chromatogra- 
phy. Unextracted membrane and H- 
2K  k (dialyzed to remove DOC) were 
applied to a silica gel G plate, dried, 
and chromatographed as described 
in Materials and Methods. The posi- 
tions of lipid standards run in parallel 
are indicated and include C, choles- 
terol; PE, phosphatidylethanolamine; 
PC,  phosphatidylcholine; and  SM, 
sphingomyelin. O designates the or- 
igin. Lipids were visualized by expos- 
ing the plate to iodine vapor. 
Figs.  1-5 must have contained inhibitor. However, the small 
amounts of lipid used relative to H-2 antigen did not contrib- 
ute to the observed inhibition. -100 ~g/ml of membrane is 
needed for 50% inhibition. Based on a ratio of 0.6 nmol of 
phospholipid per microgram of  membrane protein, this would 
correspond to about 60 nmol of lipid.  In contrast, H-2 anti- 
gen-containing liposomes were prepared using 10 nmol or less 
lipid per microgram of H-2 antigen. Thus, over the dose range 
needed to observe inhibition by the H-2 antigen preparations 
(0.5-2 ~g), the added lipid was present in too low an amount 
to be inhibitory, as shown by the absence of activity in the 
control liposomes lacking the H-2 antigen. 
Thin-layer chromatography was  done to assess  the lipid 
composition of inhibitor preparations.  Affinity-purified H- 
2K  k (dialyzed to remove DOG) and membranes were applied 
to a silica gel G plate, developed with chloroform/methanol/ 
water (60:35:8),  and  lipids were visualized by exposure to 
iodine vapor. At least  10 lipid species,  including the major 
phospholipids, were detected in the membrane sample (Fig. 
6,  lane A).  In  comparison, only three iodine-staining spots 
were detected in the H-2 antigen sample (Fig. 6, lane B). The 
amounts of membrane and H-2 antigen run in lanes A and B 
(Fig. 6) had equal growth-inhibitory activity, as measured in 
the B cell mitogenic response assay, and comparison of these 
samples indicates that the growth inhibitor is a minor lipid or 
lipid-like component of the membrane. Large-scale purifica- 
tion and characterization of the inhibitor is in progress. 
DISCUSSION 
Plasma membranes isolated from lymphoid cells inhibit the 
in vitro growth of both normal lymphocytes and lymphoid 
tumor cells (15).  The inhibitory component(s) of the mem- 
brane was found to co-purify  with H-2K and D antigens when 
these cell surface glycoproteins were purified by monoclonal 
antibody-affinity chromatography. Insensitivity of the inhib- 
itory activity to protease and heat treatment indicated that 
the  H-2  glycoprotein was  not  the  inhibitor,  and  this  was 
confirmed by demonstration that plasma membranes from a 
cell line lacking surface H-2 antigens had inhibitory activity. 
Furthermore, the inhibitor could be separated from the H-2 
glycoprotein by gel filtration in DOC-containing buffer. The 
properties of the inhibitor suggested  that it might be a lipid 
or lipid-like membrane component, and this was confirmed 
by the finding that inhibitory activity could be extracted from 
H-2 preparations and from membranes by organic solvents. 
Comparison of the lipid content of H-2K  k and  membrane 
extracts having equal  inhibitory activity indicated that  the 
inhibitor is a minor lipid component of the membrane. 
Although  the  growth  inhibitor  is  not  H-2K  or  D,  nor 
dependent on them for activity, it co-purified with the glyco- 
proteins during affinity chromatography on MAb-Sepharose 
columns specific for the H-2  antigens.  Plasma  membranes 
cause 50% growth inhibition at 20-80 vg/ml (15) whereas H- 
2 antigen preparations have comparable activity at 0.5-6 vg/ 
ml. Thus, the inhibitor was purified at least 10-40-fold with 
respect to the membrane protein. It was also highly purified 
with respect to membrane lipids,  as shown by comparison of 
the lipid content of membrane and H-2 preparations having 
equal inhibitory activity (Fig. 6). The basis for the co-purifi- 
cation of inhibitor and H-2 antigens has not been determined, 
but these findings suggest the possibility that H-2 glycopro- 
teins and inhibitor may be associated. If so, this association 
is retained in TX-100 during solubilization and affinity chro- 
matography but is not seen in DOC, in that the glycoprotein 
and inhibitor are separated by gel filtration in this detergent. 
These results might be explained by the observation that H-2 
antigens  undergo  a  partial  and  reversible denaturation  in 
DOC, as evidenced by lower affinity binding to MAbs and 
increased susceptibility to proteolytic cleavage in this deter- 
gent in comparison to TX-100 (33). A detailed examination 
of  the possibility of  H-2 antigen association with the inhibitor, 
and the basis  for their co-purification, will be possible once 
the inhibitor has been characterized and obtained in radiola- 
beled form. 
The small size of the inhibitor-bearing liposomes made it 
possible  to directly examine the reversibility of growth inhi- 
bition. Even after several days in the presence of profoundly 
inhibitory concentrations of liposomes, cells rapidly resumed 
growth upon removal or dilution of the liposomes (Fig.  2). 
This confirms and  extends the  findings made using mem- 
branes (15), which indicated that the inhibitor was acting to 
slow the rate of cell growth without increasing the rate of cell 
death. The reversibility of membrane-mediated growth inhi- 
bition  suggests  possible  parallels with  the  observation that 
density-arrested lymphoid cells rapidly resume growth upon 
dilution to lower density (14). 
Several properties of the growth inhibition suggest that it 
may occur under normal conditions via cell-cell contact when 
cells are at high density, possibly by surface receptor recogni- 
tion of the inhibitor. The inhibitory activity is localized to the 
plasma membrane and membranes are active at concentra- 
tions of 20-80 #g/ml  (15).  Based on yields obtained upon 
membrane purification (15,  16), it can be estimated that this 
is the amount of plasma membrane present on ~ 1-4 x  107 
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of 2-6 x  106 cells/ml reached by lymphoid cells in vitro. The 
agreement is better if one considers the fact that some fraction 
of the membrane vesicles are probably present in an inside- 
out configuration (with the outside surface thus inaccessible) 
(34). Although accurate quantitation of the inhibitory concen- 
tration of purified  inhibitor will  not be  possible  until it  is 
better characterized, it appears that it is active at very low 
(probably < 1 #g/ml) concentrations. Furthermore, cells show 
a very sharp (often sigmoidal) dose .response to the inhibitor, 
with inhibition going from 0  to almost 100%  over a two- to 
fourfold concentration range (Figs.  1,  3,  and  5).  This is in 
contrast to many drugs which inhibit cell growth with a dose 
response curve over a one log or more concentration range. 
If inhibition by the membrane lipid is mediated via surface 
receptor recognition, its ready reversibility would indicate that 
continued interaction of the receptors with the inhibitor is 
necessary to maintain inhibition. 
It is also possible that inhibition by the membrane com- 
ponent involves a  mechanism other than  recognition by  a 
surface receptor. The lipid-like nature of the component raises 
the possibility that inhibition could occur via a lipid exchange 
process to result in transfer of inhibitor from membranes or 
liposomes  to  cells.  However,  because  membranes  inhibit 
growth of the same type of cells that they are obtained from, 
it is unclear that an exchange process could result in a  net 
change  in  the composition of the cell  surface membranes. 
Understanding of the mechanism of action of the inhibitor 
will clearly require further study. 
Membranes from 3T3  cells inhibit the in vitro growth of 
3T3 cells (9,  10) and the available evidence indicates that the 
inhibitory component(s) is a  membrane protein(s) (11-13). 
In contrast, the inhibitory component of lymphocyte mem- 
branes is a lipid or lipid-like molecule whose activity does not 
depend  on  membrane  proteins.  A  variety  of evidence  has 
suggested  potential  roles  for  cell  surface lipids  in  cell-cell 
interactions which control growth or differentiation (reviewed 
in references 35, 36). To our knowledge, the results described 
here are the first demonstration of the occurrence of a mem- 
brane lipid that has profound but readily reversible growth 
inhibitory activity in both the native plasma membrane and 
in highly purified form, and that is active at concentrations 
consistent with its having a role in mediating density-depend- 
ent growth arrest. Structural characterization of the inhibitor 
(in progress) will provide the basis  for further investigating 
the  mechanism  of inhibition  and  its  physiological  role  in 
growth  control.  The  fact  that  this  membrane  comoonent 
inhibits lymphoid tumor cell growth also raises the possibility 
of its potential use in control of in vivo tumor growth. 
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